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Cell replacement therapy in Parkinson’s disease (PD) still lacks a study addressing the acquisition of electro-
physiological properties of human grafted neural stem cells and their relation with the emergence of behavioral 
recovery after transplantation in the short term. Here we study the electrophysiological and biochemical pro-
files of two ventral mesencephalic human neural stem cell (NSC) clonal lines (C30-Bcl-XL and C32-Bcl-XL) 
that express high levels of Bcl-XL to enhance their neurogenic capacity, after grafting in an in vitro parkinso-
nian model. Electrophysiological recordings show that the majority of the cells derived from the transplants are 
not mature at 6 weeks after grafting, but 6.7% of the studied cells showed mature electrophysiological profiles. 
Nevertheless, parallel in vivo behavioral studies showed a significant motor improvement at 7 weeks post-
grafting in the animals receiving C30-Bcl-XL, the cell line producing the highest amount of TH+ cells. Present 
results show that, at this postgrafting time point, behavioral amelioration highly correlates with the spatial 
dispersion of the TH+ grafted cells in the caudate putamen. The spatial dispersion, along with a high number of 
dopaminergic-derived cells, is crucial for behavioral improvements. Our findings have implications for long-
term standardization of stem cell-based approaches in Parkinson’s disease.
Key words: Human neural stem cells (hNSCs); Parkinson’s disease (PD); A9-dopaminergic phenotype; 
Electrophysiology; Ventral mesencephalon
INTRODUCTION
Clinical research on cell replacement therapy (CRT) 
provided proof of principle of the therapeutic efficacy of 
dopaminergic transplants for Parkinson’s disease (PD) 
on a long-term basis, using fresh human ventral mesen-
cephalic (VM) tissue1,2. At present, human neural stem 
cells (hNSCs) and human induced pluripotent stem cells 
(hiPSCs) show great promise for CRT for neurological 
disorders3. Motor deficit amelioration has been reported 
for parkinsonian animals transplanted with human clonal 
neural stem cells in the short4 and the long term5. It has 
been recently reported that, in long-term experiments, 
motor amelioration depends on previous graft integration 
and dopamine (DA) release of the transplanted human 
embryonic stem cells (hESCs) in the long term6.
Nevertheless, little is known about the dynamics of 
how motor amelioration develops in the short term. In the 
present study, we analyze what DA-dependent variables 
may influence behavioral amelioration in parkinsonian 
models in the short term. For this, we used hVM-NSCs 
with different dopaminergic potentials, clones 30 and 32 
(described in the study by Ramos-Moreno et al.4), that 
are forced to overexpress Bcl-XL to maintain their neuro-
genic capacity7. hVM-NSC clones were grafted into an in 
vitro parkinsonian model to study their functional matu-
ration and integration at 6 weeks, while hemiparkinso-
nian animals received both clones for in vivo behavioral 
and immunohistochemical analyses.
Our results show that the hVM-NSC cell deriva-
tives display immature neuronal properties in the short 
term—6 weeks postgrafting. However, out of 45 total 
recorded cells, 1 C30-Bcl-XL- and 2 C32Bcl-XL-derived 
cells showed mature neuronal electrophysiological pro-
files, one of them fitting with the reported dopaminergic 
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firing. Despite the immature electrophysiological pro-
file of the majority of in vitro-examined cells at this 
time point, parkinsonian animals transplanted with the 
C30-Bcl-XL clone undergo a behavioral amelioration. 
Histological analyses confirmed the presence of inte-
grated human tyrosine hydroxylase (TH+) cells derived 
from both transplanted cell lines in the striatum and 
the coexpression of markers for neuronal maturation 
such as Map2ab and vesicular monoamine transporter 2 
(VMAT2). The correlation analysis shows that behav-
ioral amelioration depends mostly on the extent of the 
caudate putamen that might be exposed to DA release 
from the transplant.
MATERIALS AND METHODS
Ethics Statement
Principles of both research with laboratory animals 
and use of stem cells were approved by the relevant 
research ethics committees: Autonomous University 
Committee for Research Ethics (permit CEI 23-564), 
Comisión de Seguimiento y Control de la Donación y 
Utilización de Células y Tejidos Humanos (permit 123-
101-1), and Comité Regional Ético de Investigación 
Clínica de la Consejería de Sanidad de la Comunidad 
de Madrid (permit OPTISTEM-DA). Additional ethics 
statements about the human fetal origin of the cells 
used in the present study can be found in the original 
reports describing the generation of the parental hVM1 
and hNS1 cell lines used here8–10. Use of animals for 
organotypical slice cultures was approved by the Lund/
Malmö Ethics Committee (permit M204-12). All ani-
mal work was designed following the 3Rs principles. 
Experiments were carried out according to the guide-
lines of the European Community (directives 86/609/
ECC and 2010/63/EU). Details of animal work and wel-
fare are described under the Animal Experimentation 
section below.
Cell Culture Procedures
The cells used in the present study were perpetuated 
with v-myc and include a Bcl-XL-overexpressing hVM 
cell line (hVM1-high Bcl-XL)7,8, used as a parallel control 
for present studies, and the two clonal derivatives of the 
parental hVM1 C30 and C324,8 Bcl-XL-overexpressing 
parallel lines (from here on designated as C30-Bcl-XL 
and C32-Bcl-XL, respectively). Briefly, to generate the 
stable C30-Bcl-XL and C32-Bcl-XL, clones C30 and C32 
were transfected with a Bcl-XL-coding plasmid (LTR-
Bcl-XL-IRES-hrGFP-LTR)7,10 using Lipofectamine 2000 
(Invitrogen, Thermo Fisher Scientific, Madrid, Spain), 
when their passage numbers were 16 and 22, respectively. 
C30-Bcl-XL+ and C32-Bcl-XL+ cells were sorted using a 
fluorescence-activated cell sorter, the FACSCalibur flow 
cytometer (BD Biosciences, Madrid, Spain) as previously 
described7. Bcl-XL overexpression was also confirmed by 
Western blot four passages later (data not shown).
Cells were routinely cultured on 10 µg/ml poly-L-lysine-
pretreated plastic ware in recombinant human epidermal 
growth factor (EGF) and basic fibroblast growth factor 
(bFGF) (20 ng/ml each; R&D Systems, Minneapolis, 
MN, USA)-supplemented chemically defined medium 
(referred to hereafter as “proliferation medium”)4,8. Cells 
were grown at 37°C, in 95% humidity, 5% CO2, and 5% 
O2 atmosphere (normoxic conditions for brain tissue) in 
a dual CO2/O2 control incubator (Forma; Thermo Fisher 
Scientific). Alternatively, for the immunocytochemistry 
assays, the cells were grown on poly-L-lysine-pretreated, 
glass coverslips. Cells were differentiated in differen-
tiation medium [proliferation medium without mitogens 
EGF or bFGF and enriched with 2 ng/ml glial cell line-
derived neurotrophic factor (GDNF; PeproTech, London, 
UK) and 1 mM dibutyryl cyclic adenosine monophos-
phate (db-AMPc; Sigma-Aldrich, Madrid, Spain)11].
Immunocytochemistry (ICC)
Cultures were fixed under proliferation conditions or 
after 10 days of differentiation with 4% buffered parafor-
maldehyde (PFA; Sigma-Aldrich). Cells on coverslips were 
incubated overnight at 4°C in 1× phosphate-buffered saline 
(PBS) containing 1% goat serum (Gibco; Thermo Fisher 
Scientific) and 0.25% Triton X-100 (Sigma-Aldrich) with 
the primary monoclonal antibodies anti-Ki-67 (1:200; 
Thermo Fisher Scientific) or anti-b-III-tubulin (1:2,000; 
Sigma-Aldrich) and primary polyclonal antibody against 
TH (1:1,000; Chemicon, Merck Chemicals and Life 
Science GesmbH, Madrid, Spain). Samples were washed 
and incubated afterward for 1 h with appropriate fluores-
cent secondary antibodies: Cy5-conjugated donkey anti-
rabbit (1:200; Jackson ImmunoResearch, Suffolk, UK), 
Cy3-conjugated goat anti-mouse (1:200; Jackson Immuno 
Research), and counterstained with Hoechst 33342 
(1:400; Life Technologies, Thermo Fisher Scientific) to 
label nuclei.
In Vitro Cell Quantification and Microscopy Analysis 
of C30-Bcl-XL and C32-Bcl-XL Cultures
In vitro quantification of cell numbers was done in trip-
licate samples (coverslips) per condition (differentiated 
vs. proliferating states) in a Leica DM IRB epifluores-
cence microscope equipped with a digital camera Leica 
DC100 (Nussloch, Germany). In some of the immuno-
fluorescence experiments, digital images were captured 
using Leica IM500 or LSM710 software. Image analyses 
were performed using the National Institutes of Health 
(NIH; Bethesda, MD, USA) ImageJ software. The total 
number of cells in each region of interest was counted 
using Hoechst 33342 nuclear counterstaining.
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Organotypic Striatal Cultures and Cell Coculture
Organotypic cultures were prepared as 250-µm-thick 
coronal hemisphere sections of postnatal days 6–8 BALB/c 
mice. After decapitation, brains were removed and each 
hemisphere was embedded in physiological agar to offer 
mechanical support while slicing coronal sections at 4°C 
in modified artificial cerebrospinal fluid (aCSF) contain-
ing 195 mM sucrose, 2.5 mM KCl, 1.25 mM NaH2PO4, 
28 mM NaHCO3, 0.5 mM CaCl2, 1 mM L-ascorbic acid, 
3 mM pyruvic acid, 7 mM glucose, and 7 mM MgCl2 
(all from Sigma-Aldrich) equilibrated with 5% CO2 in 
oxygen. Sections were selected to include striatum and 
the overlying cortex. After slicing, sections were kept in 
ice-cold washing medium containing Hank’s balanced 
salt solution (HBSS) with 20 mM 4-(2-hydroxyethyl)-1- 
piperazineethanesulfonic acid (HEPES), 17.5 mM glu-
cose, 0.88 mM NaOH, and 1% penicillin/streptomycin 
(all from Gibco; Thermo Fisher Scientific, Waltham, MA, 
USA) for 15 min before placing individual slices on mem-
brane inserts (PICM01250; Millipore, Merck Chemicals 
and Life Science GesmbH, Stockholm, Sweden) in 240 µl 
of cell culture medium in 12-well plates. The cultur-
ing medium contained 50% minimum essential medium 
(MEM), 25% horse serum, 18% HBSS, and 2% B27, 
supplemented with 0.5% penicillin/streptomycin, 2 mM 
glutamine (all from Life Technologies, Thermo Fisher 
Scientific), 11.8 mM glucose, 20 mM sucrose, 30 ng/
ml brain-derived neurotrophic factor (BDNF; R&D Sys-
tems), 30 ng/ml GDNF (R&D Systems), and 0.2 mM 
L-ascorbic acid. Slices were cultured as interface cul-
tures at 37°C, 5% CO2, and 90% humidity. Medium was 
changed on day 1 of culturing and three times per week 
thereafter. B27 was withdrawn from the medium after 
1 week. In vitro grafting was performed on day 1 after 
slice cultures had been prepared. Prior to micrografting, 
C30-Bcl-XL, C32-Bcl-XL, and hVM1-Bcl-XL cells were 
trypsinized (Gibco; Thermo Fisher Scientific), spun down 
at 890 × g, and resuspended in Ca2+- and Mg2+-containing 
HBSS (Invitrogen, Thermo Fisher Scientific) to reach 
a concentration of 5 × 103cells/µl. Between 10,000 and 
15,000 cells were placed on the striatal region of each 
slice using an Eppendorf micropipette (Eppendorf Nordic 
A/S, Hoersholm, Denmark). Coculturing conditions were 
as described above for organotypic cultures (for more 
information see Tonnesen et al.12).
Electrophysiology
After 6 weeks in coculture, the electrophysiological 
properties of grafted clones that were green fluorescent 
protein-positive (GFP+) cells in the slices and all Bcl-XL 
cells that also express Renilla raniformis humanized 
GFP were assessed as previously described12. Slice cul-
tures were transferred on their culturing membrane to a 
recording chamber continuously perfused at 4 ml/min 
with aCSF containing 119 mM NaCl, 2.5 mM KCl, 
1.3 mM MgSO4, 2.5 mM CaCl2, 26.2 mM NaHCO3, 
1 mM NaH2PO4, and 11 mM glucose (300 mOsm, pH 
7.4; all from Sigma-Aldrich) at 32.5°C. For whole-cell 
patch-clamp recordings, a pipette solution containing 
122.5 mM K-gluconate, 17.5 mM KCl, 8 mM NaCl, 
10 mM KOH-HEPES, 0.2 mM KOH-EGTA, 2 mM 
MgATP, and 0.3 mM Na3GTP (295 mOsm, pH 7.2; all 
from Sigma-Aldrich) was used, yielding a tip resistance 
of 3–6 MW. Biocytin (Biotium, Fremont, CA, USA) was 
included in the pipette solution at 0.5–1 mg/ml to retro-
spectively identify recorded neurons. GFP-expressing 
cells were visualized using a wide-band excitation filter 
(420–480 nm), and whole-cell and patch-clamp record-
ings were made using infrared differential interference 
contrast video microscopy (BX50WI; Olympus Sverige 
AB, Stockholm, Sweden).
Resting membrane potential (RMP) was recorded in 
current clamp mode at 0 pA immediately after estab-
lishing the whole-cell configuration, while postsynaptic 
currents were recorded in voltage clamp mode holding 
the RMP at −70 mV. Rectification and action potential 
threshold were determined from stepwise de- or hyper-
polarization of the membrane potential by injecting posi-
tive or negative square current pulses for 0.5 s at 20- to 
40-pA increments from RMP (0 pA). Step current depo-
larizations were used to determine the action potential 
threshold. Duration of afterhyperpolarization following 
action potentials was measured as the entire duration of 
the membrane potential below RMP immediately fol-
lowing action potentials. All currents and voltages were 
registered and controlled using a HEKA EPC10 amplifier 
(HEKA Elektronik, Lambrecht/Pfalz, Germany). Mini 
Analysis software (Synaptosoft Inc., Fort Lee, NJ, USA) 
was used for detection and analysis of spontaneous post-
synaptic currents. Their rise time was measured as the 
time between 10% and 90% of the maximum amplitude, 
while the decay time was first fitted with a single expo-
nential and then measured as above.
Animal Experimentation: Lesion, Drug-Induced 
Rotation, and Transplantation Procedures
Animals used in this study were 3-month-old female 
Sprague–Dawley rats (Harlan Laboratories, Barcelona, 
Spain) weighing 200–250 g at the beginning of the 
experiment. Animals were housed in a temperature- and 
humidity-controlled room, under a 12 h-light/dark cycle, 
with ad libitum access to food and water. Rats received 
a 3-µl injection of 6-hydroxydopamine (6-OHDA) (9 µg 
6-OHDA in 0.2 mg/ml ascorbic acid in saline; Sigma-
Aldrich) in the right medial forebrain bundle at the fol-
lowing stereotaxic coordinates (tooth bar set at −3.3 mm): 
anteroposterior, −3.7 mm (from bregma); mediolateral, 
−1.6 mm (from bregma); and dorsoventral, −8.8 mm 
Delivered by Ingenta to: Centro de Biologia Molecular Severo Ochoa
IP: 150.244.206.36 On: Mon, 06 Mar 2017 12:23:42
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
publisher reference, volume number and page location.
2086 MARTÍNEZ-SERRANO ET AL.
Delivered by Ingenta to: Centro de Biologia Molecular Severo Ochoa
IP: 150.244.206.36 On: Mon, 06 Mar 2017 12:23:42
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
publisher reference, volume number and page location.
SHORT-TERM hNSC GRAFTS IN A PARKINSONIAN MODEL 2087
(from dura). The injection rate was 1 µl/min, and the nee-
dle was kept in place for an additional 5 min before being 
slowly retracted. Four weeks after the lesion, the rats were 
tested for drug-induced rotational behavior in automated 
rotometer bowls (Panlab S.L.U., Barcelona, Spain) fol-
lowing an intraperitoneal (IP) injection of D-amphetamine 
sulfate (5 mg/kg; Sigma-Aldrich). Rotation scores were 
collected every 2 min for 90 min in a computer-assisted 
rotometer system (Panlab). Only rats exhibiting five or 
more ipsilateral rotations/min after D-amphetamine injec-
tion were selected for transplantation studies. After bal-
ancing the experimental groups (7–10 animals per group), 
the hemiparkinsonian rats were transplanted with cells in 
proliferative state. Cells were trypsinized (Gibco; Thermo 
Fisher Scientific) and resuspended in Ca2+- and Mg2+-
containing HBSS (Invitrogen, Thermo Fisher Scientific) 
at densities of 105/µl. Cell suspensions (3 µl, a total of 
3 × 105 cells per deposit) were injected into the denervated 
striatum in a single track and deposited at the following 
coordinates (tooth bar set at −2.3): anteroposterior, +1 mm 
(from bregma); mediolateral, −3 mm (from bregma); and 
dorsoventral, −4.5 mm (from dura). The animals were 
immunosuppressed with daily IP cyclosporin A injection 
(15 mg/kg; Novartis, Barcelona, Spain) starting 2 days 
before transplantation and throughout the experiment. 
A few animals in this experiment were allowed to survive 
for 12 weeks to study the glial scar surrounding the cell 
bolus. Since animals transplanted with polyclonal hVM1-
high Bcl-XL cells have been previously reported not to 
show behavioral amelioration at short-term postgrafting4,5, 
and the use of clones has been reported to be more effec-
tive and suitable for preclinical studies4, only C30-Bcl-XL 
and C32-Bcl-XL were used for transplantation.
Immunohistochemistry (IHC)
Seven weeks after transplantation, the animals were 
sacrificed with an overdose of chloral hydrate and intra-
cardially perfused with 4% PFA (in 0.1 M phosphate 
buffer, pH 7.4). Brains were removed, postfixed for 
12 h in the same fixative at 4°C, and dehydrated in 
30% sucrose solution at 4°C until they sunk. Ten series 
of 30-µm-thick coronal sections were collected using a 
freezing microtome (Leica Biosystems, Bromma, Sweden). 
Serial free-floating sections were incubated overnight at 
4°C in PBS containing 1% goat serum and 0.25% Triton 
X-100 with the following primary antibodies: polyclonal 
anti-glial fibrillary acidic protein (GFAP) (1:1,000; 
Dako, Agilent, Santa Clara, CA, USA), ionized calcium- 
binding adaptor molecule 1 (Iba-1) (1:1,200; Wako 
Chemicals GmbH, Neuss, Germany), and TH (1:400; 
Pel-Freez, Rogers, AR, USA), and monoclonal antibodies 
against human nuclei (HuNu) (1:100; Chemicon, Merck 
Chemicals and Life Science GesmbH), Ki-67 (1:200; 
Thermo Fisher Scientific), VMAT2 (1:500; Chemicon, 
Merck Chemicals and Life Science GesmbH); Map2ab 
(1:1,000; Thermo Scientific Pierce Antibodies, Thermo 
Fisher Scientific), 4¢,6-diamidino-2-phenylindole (DAPI; 
1:1,000; AnaSpec, Fremont, CA), human cytoplasmic 
marker sc-121 (1:500; Takara Laboratories, Madrid, 
Spain), and antibody specific for human GFAP sc-123 
(1:500; Takara Laboratories). Sections were washed and 
incubated for 1 h with appropriate secondary antibodies, 
biotinylated goat anti-rabbit (1:200; Vector Laboratories, 
Burlingame, CA, USA), biotinylated rabbit anti-sheep 
(1:200; Vector Laboratories), Cy5-conjugated donkey 
anti-mouse (1:200; Jackson ImmunoResearch), and Cy3-
conjugated goat anti-rabbit (1:200; Jackson Immuno 
Research). The biotinylated sections were then incu-
bated with an avidin–biotin–peroxidase complex (ABC 
Kit; Vector Laboratories) and developed with 1,3-di-
aminobenzidine (DAB; Sigma-Aldrich) or VIP reagent 
(Vector Laboratories). Finally, all sections were mounted 
onto gelatinized glass slides (Menzel-Glaser; Thermo 
Fisher Scientific), dried overnight, mounted with Mowiol 
(Calbiochem, Merck Chemicals and Life Science 
GesmbH), and coverslipped.
FACING PAGE
Figure 1. Polyclonal hVM-Bcl-XL cells and clones 30-Bcl-XL and 32-Bcl-XL were grafted into organotypic cultures, a model for PD12, 
and allowed to mature for 6 weeks, at which point their electrophysiological properties were studied. Action potentials (APs) were 
induced upon 5- and 10-pA increments of current step injection 6 weeks after grafting. (A) Attending to their AP firing, the following 
maturational stages were recorded: completely immature (a), immature APs (b), and mature APs (c). Note that no mature APs were 
recorded for the hVM-Bcl-XL cell line, probably due to a low probability of finding such cells, as the majority of cells are immature. 
The frequency of firing in column c (15 Hz) and sag component (arrows) are characteristic of dopaminergic firing patterns upon 
stepwise depolarization current injection19. (B) Column on the left shows 1-µm-thick confocal image of the patched GFP-expressing 
C30-Bcl-XL cell stained for TH. This cell showed immature APs upon stepwise depolarization currents (traces represented in Ab). 
Scale bar: 20 µm. Column on the right shows 1-µm-thick confocal image of the recorded GFP-expressing grafted C32-Bcl-XL cell 
stained for TH. Its correspondent trace is represented in Ac showing mature DA electrophysiological profile. Both morphologies 
resemble the DA morphology described for TH+ cells in substantia nigra (reported in Grace and Onn13). Arrows point to an axonal 
process. Scale bar: 5 µm. (C) Spontaneous postsynaptic events (a) corresponding to a completely immature hVM-Bcl-XL cell (Aa) and 
(b) corresponding to the C32-Bcl-XL showing mature APs (Ac, B). Note the spontaneous discharge in (D). Whole-cell recordings in 
current-clamp mode of the C32-Bcl-XL cell shown in (Ac) and the right column in (B). (a) Characteristic dopaminergic spontaneous 
1- to 10-Hz trains of firing can be observed. Spikes in boxes are shown in more detail in (b), where the AP threshold and the slow 
membrane depolarization can be observed.
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Quantification and Microscopical Analysis of the 
Grafted Cells Into the Striatum In Vivo
The total number of HuNu+, Ki-67+, and TH+ cells in 
the graft was stereologically determined using CAST Grid 
software (Visiopharm, Hoersholm, Denmark) in three 
animals randomly taken per group. For colocalization of 
HuNu and Ki-67 antibodies, around 500 cells per animal 
were counted in random fields from the graft area in an 
epifluorescence microscope (Olympus BX61; Olympus 
Sverige AB; Solna, Stockholm, Sweden).
Results were expressed as percentage of total num-
ber of Ki-67+ cells. TH+ cell counting and morphology 
were assessed in the same animals. Colocalization of 
different markers was validated using a confocal micro-
scope (Leica).
The same three animals per group underwent optical 
density (OD) measurements, at three to four fields at 10× 
magnification per slice covering the entire caudate puta-
men, from its appearance in the anterioposterior axis until 
the appearance of the third ventricle. The software ImageJ 
was used for the area quantification and OD. Pictures of 
substantia nigra at the same levels were measured for 
determining the lesion.
Data Analysis
All behavioral testing was conducted by investigators 
blind to the treatments of the rats. Statistical analysis was 
used to compare groups for signed rank test with a sig-
nificance level of p < 0.05.
Analysis of electrophysiological data was performed 
using Fitmaster (HEKA Elektronik) and Igor Pro (Wave-
metrics, Portland, OR, USA). A one-tailed Student’s 
t-test was applied to analyze differences in the electro-
physiological properties and number of Ki-67+ cells of 
the hVM1-Bcl-XL, C30-Bcl-XL, and C30-Bcl-XL grafted 
cells. The level of significance was p £ 0.05. All data are 
presented as mean ± standard error of the mean (SEM). 
Correlation analysis of the OD and cell counting was 
performed using StatPlus:mac version 6 (AnalysisSoft 
Inc., Walnut, CA, USA).
RESULTS
Electrophysiological Maturation and Synaptic 
Integration of the Genetically Modified Human 
Clones After Grafting
C30-Bcl-XL and C32-Bcl-XL cells were grafted onto 
striatal coronal slices, which can be considered as an in 
vitro model of PD12, and cocultured for 6 weeks to study 
the functional properties, maturation, and integration of 
the hVM-NSC clones after transplantation.
Most of the grafted hVM-NSCs displayed immature 
neuronal properties 6 weeks postgrafting. A total of 42 
cells showed either no action potentials (APs) or imma-
ture APs upon stepwise depolarization by current injec-
tion (Fig. 1A and Table 1). However, relatively mature 
APs were recorded in one C32-Bcl-XL cell, which is 
documented to be a transplanted cell with biocytin dif-
fused from the recording pipette (Fig. 1Ac and B) and 
in two other cells (one C30-Bcl-XL cell and one C32-
Bcl-XL cell), visually confirmed for GFP expression dur-
ing the electrophysiological recording. Out of these three 
cells, the two cells belonging to the C32-Bcl-XL group 
showed spontaneous firing in current-clamp mode, and 
one of them showed a low-frequency regular AP firing 
activity (Fig. 1D). The profile also included broad APs 
followed by a pronounced afterhyperpolarization and a 
“sag” component induced by step current hyperpolariza-
tion, all characteristic for midbrain nigral DA neurons13–15 
(see Fig. 1Ac).
RMPs and input resistance (Ri) data for recorded cells 
are shown in Table 1. RMPs were −61.4 ± 3.3 mV for 
the hVM1-Bcl-XL cells, −48.96 ± 6.07 mV for the C30-
Bcl-XL cells, and −56.64 ± 3.67 mV for the C32-Bcl-XL 
cells. Ri values were 1,990 ± 478 MW for the hVM1-
Bcl-XL cells, 1,487.48 ± 393 MW for the C30-Bcl-XL cells, 
Table 1. Electrophysiological Properties of the 45 Different hVM1 Cell-Derived Neurons at 6 Weeks Postgrafting in Organotypical 
Striatal Slices
Immature (42 Cells) Mature (3 Cells)  
hVM1-Bcl-XL C30-Bcl-XL C32-Bcl-XL hVM1-Bcl-XL* (1) C30-Bcl-XL (2) C32-Bcl-XL
1,990 ± 478 1,487.48 ± 393 1,500.39 ± 386.76 − 396.19 424.24 ± 312 Ri (MW)
−61.40 ± 3.3 −48.96 ± 6.07 −56.64 ± 3.67 − −52.4 −58.28 ± 11.77 RMP
−4.62 ± 7.19 −10.13 ± 5.11 −17.82 ± 9.09 − −38.26 −36.23 ± 5.89 AP thresh (mV)
27.19 ± 11.91 21.33 ± 5.49 45.36 ± 12.96 − 80.91 71.41 ± 1.40 AP ampl (mV)
11.25 ± 6.31 5.63 ± 1.91 2.61 ± 0.91 − 1.3 1.27 ± 1.15 AP ½ dur (ms)
5.25 ± 3.98 0.70 ± 3.74 11.20 ± 3.35 − 11 14.04 ± 7.67 AHP (mV)
*No electrophysiologically mature cell was recorded for hVM1-Bcl-XL. (1) Only one of the recorded neurons derived from the C30-Bcl-XL cells 
showed APs. (2) Two of the recorded neurons derived from the C32-Bcl-XL cells showed APs. Please note the AP threshold (around −40 mV) and the 
high AP amplitudes and AHP values, characteristic of dopaminergic neurons when recorded in vivo in rats13,19. Data are presented as mean ± standard 
error of the mean (SEM). AP, action potential, AHP, afterhyperpolarization.
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and 1,500.39 ± 386.76 MW for the C32-Bcl-XL cells. No 
statistical significance was observed between the groups.
Spontaneous postsynaptic currents (sPSCs) recorded 
at −70 mV in whole-cell voltage-clamp mode showed 
that out of the 45 recorded hVM1 cell-derived neurons 
recorded, 7 cells [1 hVM1-Bcl-XL cell, 2 C30-Bcl-XL 
cells (1 immature and 1 mature firing profile) and 4 C32-
Bcl-XL cells (2 immature and 2 mature firing profiles)] 
displayed sPSCs 6 weeks after grafting. Cells were first 
identified under the microscope by their GFP expression, 
and four could be later confirmed with biocytin (one 
hVM1-Bcl-XL, one immature C30 Bcl-XL, one immature 
C32 Bcl-XL, and one mature C32 Bcl-XL).
Immunohistochemical and Quantitative Studies of 
hVM1 C30-Bcl-XL and C32-Bcl-XL Cell Grafts In Vivo
Our data show that while some of the ex vivo-grafted 
cells may express TH but do not fire any AP, all cells 
with characteristic DA AP firings are TH immuno-
reactive (Fig. 1B).
IHC confirmed graft survival and cytoarchitectural 
integration in the recipient tissue in the in vivo short-term 
studies (7 weeks postgrafting). The grafts’ appearance 
was rounded and rather compact, similar to that shown by 
human and rodent fresh VM tissue grafts, containing many 
TH+ cells located around the injection site in the striatum 
for C30-Bcl-XL (Figs. 2A and 3E–G). Animals receiving 
C30-Bcl-XL showed a better production of TH+ cells and 
a higher TH+ immunoreactivity extension when compared 
to C32-Bcl-XL grafts (Fig. 3E). OD measurements of the 
TH stain between groups revealed statistical differences. 
OD values were 71,837.34 ± 2.3 and 4,479.02 ± 0.31 
arbitrary units for C30-Bcl-XL and C30-Bcl-XL, respec-
tively. Extension of the percentage of the area being reac-
tive to TH was 5.05 ± 0.93 and 0.18 ± 0.09 for C30-Bcl-XL 
and C30-Bcl-XL, respectively (data expressed as the 
mean ± SEM; p < 0.001) (Fig. 2C and D). No difference in 
OD measured in the region of the substantia nigra between 
analyzed cases was observed (data not shown). In addition, 
stereological cell counting also showed significance for 
the TH+ surviving cells between grafted groups (Fig. 2D). 
Specifically, TH-immunoreactive cell numbers were 
462,741.67 ± 233,802.38 and 24,880.95 ± 22,219.28 cells 
per transplant for C30-Bcl-XL and C30-Bcl-XL (mean ± 
SEM; p £ 0.05).
Both C30-Bcl-XL- and C30-Bcl-XL-derived cells showed 
expression of VMAT2 and Map2ab (Fig. 2B). In addi-
tion, both hVM-NSC clone transplants contain similar 
percentage of Ki-67+ cells in the grafts, 30.76 ± 6.55 and 
29.51 ± 1 for C30-Bcl-XL and C30-Bcl-XL, respectively 
(Fig. 2F). Finally, the human cytoplasmic marker sc-121 
immunostaining denotes a similar survival rate between 
grafted animals (Fig. 3F).
Glial Reactivity Surrounding the Graft Core
The glial scar surrounding the graft core (HuNu+ 
cells) shows GFAP Iba-1+ cells vastly protruding into 
the transplanted cell bolus (Fig. 4A and B). Within the 
graft, few macrophages can be detected by hemosiderin 
deposits like those in the needle track of sham-operated 
animals. Glial response is also detectable further from 
the graft core (1.7 mm medial) but comparable to that on 
nontransplanted animals, indicating that it is not a spe-
cific glial response toward the grafted cells. Migrating 
FACING PAGE
Figure 3. (A) Graph shows amphetamine-induced rotation counts pregrafting and 7 weeks following in vivo transplantation. Animals 
grafted with the naive clones behave as previously described5. Animals receiving C30-Bcl-XL cells show a significant improvement of 
their rotational asymmetry (*p £ 0.05, Wilcoxon signed rank test, two tailed; *p < 0.05, Student’s t-test; n = 7–10). Data are expressed 
as the mean ± SEM. (B) Correlation between drug-induced behavior in transplanted animals with C30-Bcl-XL and TH+ cell numbers in 
the caudate putamen at 7 weeks postgrafting (R = 0.77; p = 0.08). (C) Correlation between OD for TH staining in the transplanted stria-
tum and TH+ cell numbers in the caudate putamen at 7 weeks postgrafting. Rat transplanted with the C30-Bcl-XL cell line (R = 0.88; 
p = 0.3). (D) Correlation between drug-induced behavior in transplanted animals with C30-Bcl-XL and OD for TH cell numbers in the 
caudate putamen at 7 weeks postgrafting (R = 0.97; p = 0.059). (E) (a, b) Representative striatal-level sections from animals grafted 
with C30-Bcl-XL cells, showing high (a) and low (b) numbers of graft-derived TH+ cells. Scale bars: 1 mm. Box 1 in (a) shows the high 
presence of TH+ cellularity of the transplant. Scale bar: 40 mm. Box 2 in (a) shows morphologically mature TH+ cell showing processes 
sprouting from the soma. Arrow points at the axon. Scale bar: 50 mm. Box 1 in (b) is the magnification showing the immature mor-
phology often seen in the TH+ cells derived from the grafted C30-Bcl-XL cells. Scale bar: 50 mm. (c) Representative TH IHC of C32-
Bcl-XL cell-grafted rat brains revealing a scant presence of TH+ cells and a more abundant presence of striatal TH+ fibers at 7 weeks 
postgrafting. Scale bar: 1 mm. Boxes 1 and 2 in (c) show the prevailing presence of TH+ striatal fibers in contrast to a scarce presence 
of TH+ cells (box 2 shows solely the presence of TH+ cells in the section). Scale bars: 100 mm (box 1), 20 mm (box 2). (d) Same case 
as in (c) at a more posterior level, where only TH+ striatal fibers can be observed. 1 indicates magnification of the box in (e) showing 
TH+ striatal fibers at a bigger magnification. Scale bar: 100 mm. (e) Immunofluorescence detecting HuNu in a consecutive section of 
the brain section shown in (c) and (d) that confirms presence of grafted C32-Bcl-XL cells. Scale bars: 1 mm (c–e). (F) Representative 
photomicrographs for striatal brain sections from rats transplanted with C30-Bcl-XL and C32-Bcl-XL. Transplanted cells show good 
survival as shown by the human cytoplasmic marker sc-121 7 weeks postgrafting. Scale bar: 1 mm. (G) A fraction of the grafted cells 
shows typical astrocytic morphology accompanied by intense GFAP expression, indicating some cells of the surviving population 
become mature astrocytes. Scale bars: 1 mm and 100 mm in the magnification. Cx, cortex; Str, striatum; Ac, accumbens nucleus; LV, 
lateral ventricle.
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hNSCs (particularly C30- Bcl-XL cells) show a close 
relationship with the host’s astrocytes and microglia 
(Fig. 4, high-magnification insets). It is worth noting 
that glia derived from the transplants seems to be pres-
ent at low numbers (Fig. 3G).
Behavioral Amelioration In Vivo
Amphetamine-induced rotation tests were carried 
out for all animal groups prior to transplantation and at 
7 weeks postgrafting. Only animals receiving C30-Bcl-XL 
cells showed a significant reduction of drug-induced rota-
tion (p < 0.05) (Fig. 3A). C30-Bcl-XL cells are the ones 
producing more TH+ cells after differentiation both in 
vitro and in vivo, these covering a higher extent of the 
caudate putamen (Figs. 2A, 3E, and 5C).
Data regarding OD measurements and cell counting 
were subsequently subjected to a linear regression analy-
sis for behavioral improvement. Although there is a pos-
sible correlation between the TH+ cell numbers and the 
behavioral improvement (R = 0.77) (Fig. 3B), the stron-
gest correlation associated to the behavioral improve-
ment is the extension of the caudate putamen covered by 
the TH+ surviving cells (R = 0.97) (Fig. 3D).
DISCUSSION
Electrophysiological Maturation and Synaptic 
Integration of the Genetically Modified Human 
Clones After Short-Term Grafting
The electrophysiological study of three groups of 
grafted hVM-NSC derivatives showed that the major-
ity (93% of cells studied) were immature 6 weeks after 
grafting. These immature membrane properties are in 
line with reported cell membrane properties of human 
origin cells after their transplantation, and this agrees 
with the notion that longer times (minimum of 6 months) 
are required for human cells to mature after transplan-
tation16–18. Nevertheless, all three groups showed RMPs 
in the range of what has been reported for in vitro nigral 
adult DA cells in rats13,19.
The interesting finding in this study is that some cells did 
mature within such a short time span. This shows the poten-
tial of the hVM-NSCs to generate functional dopaminer-
gic cells after grafting. This should be confirmed in future 
long-term studies, where cells will be allowed to mature 
6 months to 1 year in in vivo grafts, where their mature 
phenotype will be assessed, along with behavioral effects.
Literature also shows that a given neuronal maturation 
stage may depend on the type of stem cell studied and/or 
the time that the cells are either maintained in culture or 
survive after grafting. For example, cocultured primary 
mouse VM neurospheres in organotypic cultures develop 
mature electrophysiological properties of DA neurons 
3 weeks after grafting12, while hiPSC-derived DA cells 
show limited maturation of their electrophysiological 
properties at 8 weeks in vitro20.
To functionally assess the extent of integration of 
hVM1 cells and derivatives in the host tissue, we aimed 
at recording sPSCs at −70 mV in whole-cell voltage-
clamp mode at 6 weeks following grafting (Fig. 6). Out 
of the 45 neurons recorded, 7 cells displayed sPSCs, 
thus proving that hVM1 cell derivatives are receiving 
synaptic inputs from other neurons, that is, that electri-
cal communication exists. Since no spontaneous activity 
was recorded in the majority of the grafted cells, synaptic 
inputs are likely to come from the host. This would be in 
accordance with a recent study that, using the rabies virus 
as a monosynaptic tracer, demonstrates the existence of 
synaptic contacts between grafted embryonic cells and 
host cells at 6 weeks postgrafting21.
TH Immunoreactivity and Behavioral 
Amelioration In Vivo
Only transplanted animals with C30-Bcl-XL cells 
showed a significant reduction of drug-induced rotation. 
This behavioral amelioration remarks the proof of princi-
ple of the therapeutic efficacy of DA transplants for PD1,2. 
C30-Bcl-XL cell derivatives produce the highest number of 
TH+-immunoreactive cells after grafting. Likewise, the 
animals receiving C30-Bcl-XL cells showed the highest 
spatial extension of TH+ surviving cells in the caudate 
putamen, this being 5.05 ± 0.9%. It has been previously 
reported that the extension of the caudate putamen receiv-
ing DA has to be higher than 4% in order to observe a 
behavioral amelioration at a similar time point22. Since in 
vitro grafting experiments show that the C30-Bcl-XL cell 
derivatives are not functionally mature at 6 weeks, we 
hypothesize that the behavioral amelioration might be due 
to the C30-Bcl-XL cells acting as biological dopaminergic 
pumps at this short-term stage. In line with the above, DA 
secreted by differentiated hVM-Bcl-XL cell derivatives 
has been detected under in vitro conditions7,23. To confirm 
this, microdialysis experiments, which measure the DA 
concentrations in vivo, could be performed. Moreover, 
behavioral amelioration in the long term has been shown 
to depend on a previous graft integration and DA release6. 
It is worth noting that the total average number of TH+ sur-
viving cells in the transplanted group showing behavioral 
improvement (462,741.67 ± 233,802.38) is in the range of 
what has been reported to be transplanted in fetal VM 
cell transplants, 450,00024. Although the final DA cells 
derived from these fetal transplants were not reported, 
micrografts covering extended extensions of the caudate 
putamen showed a motor recovery in the short term, an 
effect that was overall more prominent than the effect 
observed in single macrograft deposit experiments24. 
The above highlights the importance of migration of the 
grafted cells.
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In addition to DA, glia-derived factors are also known 
to play a role in ameliorating drug-induced behavior in the 
short term25,26. These glia-derived factors can be secreted 
either by macrophages or microglia25, by the host reac-
tive astrocytes26, or by the astrocytes derived from the 
grafted cells7. Glia-derived factors have been reported to 
neuroprotect and help in regenerating TH-immunoreactive 
fibers in parkinsonian models27–29. Our present results 
cannot exclude that secretion of glia-derived factors by 
different host cells and/or presence of auto-regenerated 
or nondegenerating host TH+ fibers might have a syn-
ergistic effect in the observed behavioral amelioration. 
Figure 5. (A) Polyclonal hVM-Bcl-XL cells and selected clones 30-Bcl-XL and 32-Bcl-XL were stained for Ki-67 or b-III-tubulin 
and TH under proliferation and 10 days under differentiation conditions. Scale bar: 20 µm for all microphotographs. (B) The graph 
represents the percentage reduction in the number of cells expressing Ki-67 after differentiation, using as reference the corresponding 
value under proliferation conditions (p £ 0.001, Student’s t-test). (C) The graph shows the percentage of neurons (b-III-tubulin+) (empty 
bar) and, from those, the percentage becomes dopaminergic (TH+) (black bar) after 10 days in vitro differentiation for the different cell 
lines (p £ 0.05, Student’s t-test; n = 3).
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Interestingly, we did not observe major differences in 
the immune response between groups (Fig. 4A and B), 
and since animals transplanted with the clone giving low 
numbers of TH+ cells and the sham group (Figs. 2A, D, 
and E, and 4E) have a nonsignificant behavioral improve-
ment (Fig. 3A), our data strongly support the therapeutic 
efficacy of DA1,2,30. Moreover, we hypothesize that a sig-
nificant amount of the DA involved in the amelioration 
should preferentially be secreted by the graft-derived DA 
cells, as there is a correlation between behavioral amelio-
ration and presence of TH+ cells (Fig. 3D), and low num-
bers of TH+ cells do not induce any amelioration of the 
rotational behavior (Fig. 3A and E). Future experiments 
using optogenetics6 and/or designer receptors exclu-
sively activated by designer drug (DREADD)31 systems 
to inhibit DA secretion from the graft-derived DA cells 
should help to unambiguously answer this question and 
also to determine the weight of the different components 
involved in the short-term amelioration.
Finally, the present results also show that although glial 
scar is dense, it still allows for communication between 
the host and the graft, tolerating migration of hNSCs 
through the neighboring parenchyma. It is known that the 
early events following the transplantation of embryonic 
Figure 6. Schematics of hVM1-derived grafted cells showing different integration and biochemical maturation rates coexisting at 
the 6-week time point. (a) Contacting cell. (b) Immature GFP+-grafted human cells do not receive inputs from the contacting cell and 
do not show any action potential (AP). A total of 26 cells with this phenotype were recorded. (c) Maturing human grafted cell starts 
expressing TH and shows a very immature AP but is not receiving any input from contacting cells either. A total of 12 cells with this 
phenotype were recorded. (d) Maturing cell expressing TH shows an immature AP and receives inputs from contacting cells. A total 
of four cells with this phenotype were recorded. (e) Integrated cell expressing TH shows characteristic dopaminergic action potentials 
with sag component (arrow). A total of three cells with this phenotype were recorded.
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mesencephalic tissue grafted to an adult brain induce 
around them the formation of a glial scar and the upreg-
ulation of several extracellular matrix molecules32. The 
gliosis surrounding grafts of embryonic tissue is present 
during the time in which TH-immunoreactive neurites are 
growing from the dopaminergic neurons of the graft into 
the host brain32. This degree of gliosis is not sufficient to 
prevent axon growth from embryonic mesencephalic neu-
rons32, and based on recent publications it is likely that the 
glial scar can be helpful in cell axon regeneration33.
Likewise, gliosis should be mild enough to allow 
cell migration for cells to cover big extensions of the 
caudate putamen. Long-term experiments (6 months to 
1 year graft survival) are needed in order to answer if 
transplanted animals with human stem cell derivatives 
of C30-Bcl-XL recover behavior because of a functional 
integration and if the glia scar can resolve after reinnerva-
tion is completed.
CONCLUSIONS AND FUTURE REMARKS
Although the majority of cells in the grafts are imma-
ture after 6 weeks under in vitro grafting conditions, 
animals receiving the more productive TH+ cell line ame-
liorate rotational behavior at 7 weeks. The highest cor-
relation with behavioral recovery in the short term is the 
extension of the caudate putamen that may be exposed 
to DA. Moreover, the present results are indicative of 
the potential of the hNSC-VM to generate functionally 
integrated dopaminergic cells after grafting. It remains 
to be studied if this functional integration and matura-
tion of C30-Bcl-XL derivatives in parkinsonian animals 
restore behavior in long-term experiments. Future long-
term (up to 1 year) translational studies will address these 
issues in a design that will also allow to study neuron 
aging of graft maturation, graft-induced dyskinesia, toxi-
cology, and safety.
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